Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Orthotopic liver transplantation (OLT) is the standard of care for patients with
decompensated cirrhosis and for patients with hepatocellular carcinoma. More than 6000 …

Liver transplantation (LT) is widely accepted as an effective therapeutic modality for a variety
of irreversible acute and chronic liver disease. The success of liver transplantation has …

Human cytomegalovirus (HCMV) infection is common and affects between 40–100% of the
worldwide population. However, the majority of cases are asymptomatic and when severe …

Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …

Cytomegalovirus (CMV) is one of the most common viral pathogens causing clinical disease
in liver transplant recipients, and contributing to substantial morbidity and occasional …

Background: In addition to the conventional opportunistic infections in solid organ
transplantation (SOT) and hematopoietic stem cell transplantation (HSCT) recipients …

Survival following liver transplantation has changed dramatically owing to improvement in
surgical techniques, peri-operative care and optimal immunosuppressive therapy. Post-Liver …

Racial/ethnic disparities in access to and outcomes of liver transplantation are an important
topic given the increasing diversity in the United States. Most reports on this topic predate …

Cytomegalovirus (CMV) infection is the most common viral infection in liver transplant
recipients, affecting post-transplant patients and graft survival. Recent advances in …